Company news
Jiangsu Kanion Pharmaceutical Co. Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Progress in Shareholding Increase by Persons Acting in Concert with Controlling Shareholders and Subsequent Shareholding Increase Plan
February 24, 2025
Announcement on Implementation Results of Share Repurchase and Share Changes
February 5, 2025
Announcement on Resignation and By-election of Independent Director
December 31, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
December 11, 2024
Announcement on Inclusion of Some Drugs in the Catalogue of Drugs for Basic National Medical Insurance
November 29, 2024
Announcement on Receiving Notice of Approval for Clinical Trial of KYS202003A Injection
November 28, 2024
Announcement on Receiving Notice of Approval for Clinical Trial of KYHY2302 Cream
November 27, 2024
Announcement on Resolution of the 14th Extraordinary Meeting of the 8th Board of Directors
November 25, 2024
Announcement on Reply to "Letter of Supervision on Related Party Transactions of Jiangsu Kanion Pharmaceutical Co., Ltd." from SSE and Adjustment of Transaction Plan
November 24, 2024
Announcement on Receiving FDA's Approval for Clinical Trial of KYS202004A Injection
November 8, 2024
Announcement on Resolution of the 13th Meeting of the 8th Board of Directors
November 7, 2024
Announcement on Progress in Repurchasing Shares through Call Auction
November 1, 2024
Report for Q3 2024
October 30, 2024
Announcement on Repurchasing 2% of the Company's Share Capital through Auction and Repurchase Progress
September 13, 2024
Announcement on Receiving Notice of Approval for Clinical Trial of KYS202004A Injection
September 5, 2024
Announcement Obtaining Drug Registration Certificate for Detoxification Granules
August 23, 2024
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
August 12, 2024
Announcement on Reply to "Letter of Supervision on Related Party Transactions of Jiangsu Kanion Pharmaceutical Co., Ltd." from SSE
August 5, 2024
Announcement on Progress in Repurchasing Shares through Auction
August 1, 2024
Announcement on Repurchasing 1% of the Company's Share Capital through Auction and Repurchase Progress
July 29, 2024